Both in R&D — Physical & Biological Sciences
NRC Health vs IB Acquisition
Over the past year NRC returned +69.4% and IBAC returned +4.1%; their daily moves had a correlation of -0.04.
NRC +69.4% IBAC +4.1%Growth of $1, one year, split-adjusted
| Metric | NRC | IBAC |
|---|---|---|
| Price | $23.83 | $10.86 |
| Market cap | $505.7M | $54.4M |
| Today | +1.45% | 0.00% |
| 1 month | +11.8% | −0.5% |
| 6 months | +36.9% | +0.4% |
| Year to date | +27.0% | +3.4% |
| 1 year | +77.2% | — |
| Revenue growth (YoY) | +4.0% | — |
| Gross margin | 61.7% | — |
| Net margin | −9.3% | — |
| P/E (TTM) | 91.1× | — |
| Price / sales | 3.6× | — |
| Net cash | -$86.7M | — |
| Dividend yield | 2.69% | — |
| Volatility (60d) | 45.5% | 20.1% |
| Short % of float | 7.2% | 0.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).